Related Experiment Video
Updated: Jul 21, 2026

Biomimetic Materials to Characterize Bacteria-host Interactions
Published on: November 16, 2015
Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci
Abstract:
When virulent group A streptococci of M type 24 were incubated in fresh heparinized whole blood or in blood reconstituted from cellular elements and plasma, little uptake by neutrophils occurred as determined by light microscopy. When fresh human serum (with or without added heparin) was substituted for plasma, uptake occurred promptly. Uptake in serum could be prevented by adding either plasma or purified human fibrinogen to the incubation mixtures, or by pretreating the organisms with plasma or fibrinogen. Fibrinogen solutions absorbed with purified homologous M protein and centrifuged to remove precipitates lost their inhibitory activity. Uptake in serum depended on heat-labile factors. Immunofluorescent staining of bacteria using fluorescein-labeled antibody to the third component of complement showed that streptococci incubated in fresh serum bound complement evenly over the entire cell surface, whereas streptococci incubated in fresh plasma or in serum plus fibrinogen fluoresced only at some of the cross-walls between adjacent daughter cocci and at occasional terminal cocci. In electron micrographs, the surface fibrillar layer of streptococci treated with plasma or fibrinogen lost its hairlike appearance and became a dark band that stained heavily with ferritin-labeled antifibrinogen. We conclude that the known antiopsonic effect of M protein derives in part from binding of fibrinogen.
Insights
Group A Streptococcus M protein hinders neutrophil uptake by binding fibrinogen. This interaction is crucial for bacterial virulence and immune evasion strategies.
Area of Science:
- Microbiology
- Immunology
- Bacteriology
Background:
- Virulent group A streptococci (GAS) possess M protein, a key virulence factor.
- Neutrophil phagocytosis is a critical host defense mechanism against bacterial infections.
- The antiopsonic effect of M protein is known to impair bacterial clearance.
Purpose of the Study:
- To investigate the mechanism by which M type 24 group A streptococci evade neutrophil uptake.
- To determine the role of plasma components, specifically fibrinogen, in this evasion process.
- To elucidate the interaction between M protein and fibrinogen during bacterial-host encounters.
Main Methods:
- Incubation of M type 24 GAS with neutrophils in various blood components (plasma, serum).
- Assessment of bacterial uptake by neutrophils using light microscopy.
- Inhibition assays using purified fibrinogen and plasma.
- Immunofluorescent staining for complement component C3 deposition.
- Electron microscopy to visualize bacterial surface changes after treatment with plasma/fibrinogen.
Main Results:
- Neutrophil uptake of GAS was minimal in plasma but prompt in serum.
- Uptake was inhibited by plasma or fibrinogen, and by pretreating bacteria with these components.
- Fibrinogen solutions lost inhibitory activity after absorption with M protein.
- Complement deposition (C3) was altered, showing reduced binding on bacteria treated with plasma/fibrinogen.
- Electron microscopy revealed changes in the bacterial surface fibrillar layer upon interaction with fibrinogen.
Conclusions:
- The antiopsonic activity of M protein is partly mediated by its binding to fibrinogen.
- Fibrinogen binding to M protein alters bacterial surface properties, potentially hindering opsonophagocytosis.
- This interaction represents a significant mechanism of immune evasion for group A Streptococcus.
More Related Videos
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Determinants of Bacterial Pathogenicity and Virulence
Streptococcal Pharyngitis
Inhibitors of Bacterial Protein Synthesis

